These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2838706)

  • 21. Effects of mu, kappa or delta opioids administered by pellet or pump on oral Salmonella infection and gastrointestinal transit.
    Feng P; Rahim RT; Cowan A; Liu-Chen LY; Peng X; Gaughan J; Meissler JJ; Adler MW; Eisenstein TK
    Eur J Pharmacol; 2006 Mar; 534(1-3):250-7. PubMed ID: 16513108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential opiate influences on food hoarding and intake in the deer mouse, Peromyscus maniculatus.
    Kavaliers M; Hirst M
    Life Sci; 1985 Dec; 37(23):2213-20. PubMed ID: 2999543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Food hoarding and ingestion in the deer mouse, Peromyscus maniculatus: selective responses to mu and kappa opiate agonists.
    Kavaliers M; Hirst M
    Pharmacol Biochem Behav; 1986 Sep; 25(3):543-8. PubMed ID: 3022306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pertussis and cholera toxins modulate kappa-opioid receptor agonists-induced hypothermia and gut inhibition.
    Shukla VK; Turndorf H; Bansinath M
    Eur J Pharmacol; 1995 Mar; 292(3-4):293-9. PubMed ID: 7796869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration schedule.
    Craft RM; Dykstra LA
    J Pharmacol Exp Ther; 1990 Mar; 252(3):945-52. PubMed ID: 1969478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mu and kappa opioid modulation of olfactory bulb evoked potentials.
    Pérez H; Hernández A; Inostroza H
    Int J Neurosci; 1989 Dec; 49(3-4):329-32. PubMed ID: 2561634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiplicative interaction between intrathecally and intracerebroventricularly administered mu opioid agonists but limited interactions between delta and kappa agonists for antinociception in mice.
    Roerig SC; Fujimoto JM
    J Pharmacol Exp Ther; 1989 Jun; 249(3):762-8. PubMed ID: 2567350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of endogenous acetylcholine release from mammalian brain slices by opiate receptors: hippocampus, striatum and cerebral cortex of guinea-pig and rat.
    Lapchak PA; Araujo DM; Collier B
    Neuroscience; 1989; 31(2):313-25. PubMed ID: 2552347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. U50,488: a kappa-selective agent with poor affinity for mu1 opiate binding sites.
    Clark JA; Pasternak GW
    Neuropharmacology; 1988 Mar; 27(3):331-2. PubMed ID: 2836756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
    Craft RM; Dykstra LA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):327-33. PubMed ID: 1309876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new analysis of whole-body calorimetry data.
    Lynch TJ; Martinez RP; Furman MB; Geller EB; Adler MW
    NIDA Res Monogr; 1989; 95():289-90. PubMed ID: 2561834
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of central mu, delta-1, and kappa-1 opioid receptors in opioid-induced muscle rigidity in the rat.
    Vankova ME; Weinger MB; Chen DY; Bronson JB; Motis V; Koob GF
    Anesthesiology; 1996 Sep; 85(3):574-83. PubMed ID: 8853088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mu, but not kappa, opioid agonists induce contractions of the canine small intestine ex vivo.
    Hirning LD; Porreca F; Burks TF
    Eur J Pharmacol; 1985 Feb; 109(1):49-54. PubMed ID: 2986990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
    Millan MJ; Członkowski A; Lipkowski A; Herz A
    J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Na+ ions and Gpp(NH)p selectively inhibit agonist interactions at mu- and kappa-opioid receptor sites in rabbit and guinea-pig cerebellum membranes.
    Frances B; Moisand C; Meunier JC
    Eur J Pharmacol; 1985 Nov; 117(2):223-32. PubMed ID: 2866971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of mu and kappa opioid receptor agonists on rat plasma corticosterone levels.
    Hayes AG; Stewart BR
    Eur J Pharmacol; 1985 Oct; 116(1-2):75-9. PubMed ID: 2996912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
    Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
    Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
    Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
    Neuroendocrinology; 1986; 42(1):75-81. PubMed ID: 3001565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antinociceptive effects of mu- and kappa-agonists in inflammation are enhanced by a peripheral opioid receptor-specific mechanism.
    Stein C; Millan MJ; Yassouridis A; Herz A
    Eur J Pharmacol; 1988 Oct; 155(3):255-64. PubMed ID: 2853065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.